IFTM University

About: IFTM University is a education organization based out in Morādābād, Uttar Pradesh, India. It is known for research contribution in the topics: Drug delivery & Controlled release. The organization has 298 authors who have published 395 publications receiving 4191 citations. The organization is also known as: Institute of Foreign Trade and Management.

Ion-exchange kinetic studies for Cd(II), Co(II), Cu(II), and Pb(II) metal ions over a composite cation exchanger

Abstract: Explicit Nernst–Planck approximation is used to study the kinetics of H(I)-metal ion-exchange processes for ions having different effective diffusion coefficients, that is, for non-isotopic exchange process. Kinetic studies of four heavy metal ions (Cd2+, Co2+, Cu2+, and Pb2+) of environmental importance on the surface of acetonitrile stannic(IV) selenite composite cation exchanger were carried out successfully. On the basis of kinetic studies, various physical parameters, that is, fractional attainment of equilibrium U(τ), self-diffusion coefficients (Do), energy of activation (Ea), and entropy of activation (ΔS*) are estimated to evaluate the mechanism of ion exchange on the surface of composite ion-exchange material. The activation entropy and energy revealed that the greater degree and minimum energy was achieved during forward ion-exchange process. The results revealed that the kinetic studies are very important for the economic and industrial applications of ion-exchange materials.

Nanotechnology-Based Cosmeceuticals

Abstract: Cosmeceuticals are the fastest growing segment of the personal care industry, and a number of topical cosmeceutical treatments for conditions such as photoaging, hyperpigmentation, wrinkles, and hair damage have come into widespread use. In the cosmeceutical arena nanotechnology has played an important role. Using new techniques to manipulate matter at an atomic or molecular level, they have been at the root of numerous innovations, opening up new perspectives for the future of cosmeceutical industry. Nanotechnology-based cosmeceuticals offer the advantage of diversity in products, and increased bioavailability of active ingredients and increase the aesthetic appeal of cosmeceutical products with prolonged effects. However increased use of nanotechnology in cosmeceuticals has raised concern about the possible penetration of nanoparticles through the skin and potential hazards to the human health. This review outlines the different nanoparticles used in various classes of cosmeceuticals, nanotechnology-based cosmeceutical products present in the market, and the potential risk caused by nanoparticles on exposure and recent regulatory steps taken to overcome them.

Carbon Nanotubes: An Emerging Drug Carrier for Targeting Cancer Cells

Abstract: During recent years carbon nanotubes (CNTs) have been attracted by many researchers as a drug delivery carrier. CNTs are the third allotropic form of carbon-fullerenes which were rolled into cylindrical tubes. To be integrated into the biological systems, CNTs can be chemically modified or functionalised with therapeutically active molecules by forming stable covalent bonds or supramolecular assemblies based on noncovalent interactions. Owing to their high carrying capacity, biocompatibility, and specificity to cells, various cancer cells have been explored with CNTs for evaluation of pharmacokinetic parameters, cell viability, cytotoxicty, and drug delivery in tumor cells. This review attempts to highlight all aspects of CNTs which render them as an effective anticancer drug carrier and imaging agent. Also the potential application of CNT in targeting metastatic cancer cells by entrapping biomolecules and anticancer drugs has been covered in this review.

Recent updates on drug resistance in Mycobacterium tuberculosis

Abstract: Tuberculosis (TB) along with acquired immune deficiency syndrome and malaria rank among the top three fatal infectious diseases which pose threat to global public health, especially in middle and low income countries. TB caused by Mycobacterium tuberculosis (Mtb) is an airborne infectious disease and one-third of the world's population gets infected with TB leading to nearly 1·6 million deaths annually. TB drugs are administered in different combinations of four first-line drugs (rifampicin, isoniazid, pyrazinamide and ethambutol) which form the core of treatment regimens in the initial treatment phase of 6-9 months. Several reasons account for the failure of TB therapy such as (i) late diagnosis, (ii) lack of timely and proper administration of effective drugs, (iii) lower availability of less toxic, inexpensive and effective drugs, (iv) long treatment duration, (v) nonadherence to drug regimen and (vi) evolution of drug-resistant TB strains. Drug-resistant TB poses a significant challenge to TB therapy and control programs. In the background of worldwide emergence of 558 000 new TB cases with resistance to rifampicin in the year 2017 and of them, 82% becoming multidrug-resistant TB (MDR-TB), it is essential to continuously update the knowledge on the mechanisms and molecular basis for evolution of Mtb drug resistance. This narrative and traditional review summarizes the progress on the anti-tubercular agents, their mode of action and drug resistance mechanisms in Mtb. The aim of this review is to provide recent updates on drug resistance mechanisms, newly developed/repurposed anti-TB agents in pipeline and international recommendations to manage MDR-TB. It is based on recent literature and WHO guidelines and aims to facilitate better understanding of drug resistance for effective TB therapy and clinical management.